ADAMTS1, a putative anti-angiogenic factor, is decreased in human prostate cancer

BJU International

Volumn 104, Issue 11, 2009, Pages 1786-1790

  Gustavsson, Heléne ^a   Wang, Wanzhong ^a   Jennbacken, Karin ^a   Welén, Karin ^a   Damber, Jan Erik ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ADAMST1; Androgen independent; Angiogenesis; Microvessel density; Prostate cancer

Indexed keywords

ADAMTS1 PROTEIN; ANDROGEN; CD34 ANTIBODY; METALLOPROTEINASE; THROMBOSPONDIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD VESSEL; CANCER CELL; CD34 SELECTION; CELL COUNT; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY; DISEASE ASSOCIATION; DISEASE COURSE; EPITHELIUM CELL; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROVASCULATURE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCORING SYSTEM; STAINING; TRANSURETHRAL RESECTION;

ADAM PROTEINS; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIGENS, CD34; DOWN-REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASMS, HORMONE-DEPENDENT; PROSTATIC NEOPLASMS;

EID: 70449420043     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08676.x     Document Type: Article

References (30)

1. Strohmeyer D, Rossing C, Strauss F, Bauerfeind A, Kaufmann O, Loening S. Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer. Prostate 2000 42 : 26 33
2. Revelos K, Petraki C, Scorilas A et al. Correlation of androgen receptor status, neuroendocrine differentiation and angiogenesis with time-to-biochemical failure after radical prostatectomy in clinically localized prostate cancer. Anticancer Res 2007 27 : 3651 3660
3. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993 143 : 401 409
4. Lissbrant IF, Stattin P, Damber JE, Bergh A. Vascular density is a predictor of cancer-specific survival in prostatic carcinoma. Prostate 1997 33 : 38 45
5. Abbaszade I, Liu RQ, Yang F et al. Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem 1999 274 : 23443 23450
6. Kuno K, Kanada N, Nakashima E, Fujiki F, Ichimura F, Matsushima K. Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene. J Biol Chem 1997 272 : 556 562
7. Rodriguez-Manzaneque JC, Milchanowski AB, Dufour EK, Leduc R, Iruela-Arispe ML. Characterization of METH-1/ADAMTS1 processing reveals two distinct active forms. J Biol Chem 2000 275 : 33471 33479
8. Liu YJ, Xu Y, Yu Q. Full-length ADAMTS-1 and the ADAMTS-1 fragments display pro- and antimetastatic activity, respectively. Oncogene 2006 25 : 2452 2467
9. Vazquez F, Hastings G, Ortega MA et al. METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J Biol Chem 1999 274 : 23349 23357
10. Luque A, Carpizo DR, Iruela-Arispe ML. ADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165. J Biol Chem 2003 278 : 23656 23665
11. Lee NV, Sato M, Annis DS et al. ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2. EMBO J 2006 25 : 5270 5283
12. Kuno K, Okada Y, Kawashima H et al. ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan. FEBS Lett 2000 478 : 241 245
13. Sandy JD, Westling J, Kenagy RD et al. Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. J Biol Chem 2001 276 : 13372 13378
14. Lind T, Birch MA, McKie N. Purification of an insect derived recombinant human ADAMTS-1 reveals novel gelatin (type I collagen) degrading activities. Mol Cell Biochem 2006 281 : 95 102
15. Torres-Collado AX, Kisiel W, Iruela-Arispe ML, Rodriguez-Manzaneque JC. ADAMTS1 interacts with, cleaves, and modifies the extracellular location of the matrix inhibitor tissue factor pathway inhibitor-2. J Biol Chem 2006 281 : 17827 17837
16. Iruela-Arispe ML, Carpizo D, Luque A. ADAMTS1: a matrix metalloprotease with angioinhibitory properties. Ann N Y Acad Sci 2003 995 : 183 190
17. Kuno K, Bannai K, Hakozaki M, Matsushima K, Hirose K. The carboxyl-terminal half region of ADAMTS-1 suppresses both tumorigenicity and experimental tumor metastatic potential. Biochem Biophys Res Commun 2004 319 : 1327 1333
18. Rocks N, Paulissen G, Quesada-Calvo F et al. ADAMTS-1 metalloproteinase promotes tumor development through the induction of a stromal reaction in vivo. Cancer Res 2008 68 : 9541 9550
19. Porter S, Scott SD, Sassoon EM et al. Dysregulated expression of adamalysin-thrombospondin genes in human breast carcinoma. Clin Cancer Res 2004 10 : 2429 2440
20. Masui T, Hosotani R, Tsuji S et al. Expression of METH-1 and METH-2 in pancreatic cancer. Clin Cancer Res 2001 7 : 3437 3443
21. Rocks N, Paulissen G, Quesada Calvo F et al. Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC). Br J Cancer 2006 94 : 724 730
22. Gustavsson H, Jennbacken K, Welen K, Damber JE. Altered expression of genes regulating angiogenesis in experimental androgen-independent prostate cancer. Prostate 2008 68 : 161 170
23. Ifon ET, Pang AL, Johnson W et al. U94 alters FN1 and ANGPTL4 gene expression and inhibits tumorigenesis of prostate cancer cell line PC3. Cancer Cell Int 2005 5 : 19
24. Huss WJ, Hanrahan CF, Barrios RJ, Simons JW, Greenberg NM. Angiogenesis and prostate cancer: identification of a molecular progression switch. Cancer Res 2001 61 : 2736 2743
25. Kosaka T, Miyajima A, Takayama E et al. Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer. Prostate 2007 67 : 41 9
26. Loberg RD, St John LN, Day LL, Neeley CK, Pienta KJ. Development of the VCaP androgen-independent model of prostate cancer. Urol Oncol 2006 24 : 161 168
27. Gustavsson H, Welen K, Damber JE. Transition of an androgen-dependent human prostate cancer cell line into an androgen-independent subline is associated with increased angiogenesis. Prostate 2005 62 : 364 373
28. Di Lorenzo G, De Placido S, Autorino R et al. Expression of biomarkers modulating prostate cancer progression: implications in the treatment of the disease. Prostate Cancer Prostatic Dis 2005 8 : 54 9
29. Cross NA, Chandrasekharan S, Jokonya N et al. The expression and regulation of ADAMTS-1-4-5-9, and -15, and TIMP-3 by TGFbeta1 in prostate cells: relevance to the accumulation of versican. Prostate 2005 63 : 269 275
30. Ricciardelli C, Mayne K, Sykes PJ et al. Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer. Clin Cancer Res 1998 4 : 963 971